Clinical trials recruiting for Liver Fibrosis
16
Recruiting trials
31
US states with sites
41
Countries
19%
Accept healthy volunteers
Phase breakdown
Phase 2 1Phase 3 2Phase 4 2Not applicable 11
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Ohio | 4 |
| Arizona | 2 |
| Florida | 2 |
| Indiana | 2 |
| Massachusetts | 2 |
| Minnesota | 2 |
| Missouri | 2 |
| Texas | 2 |
| Alabama | 1 |
| California | 1 |
| Colorado | 1 |
| Connecticut | 1 |
Top cities
Columbus, Ohio 3Bellaire, Texas 2Boston, Massachusetts 2Columbia, Missouri 2Miami, Florida 2San Antonio, Texas 2Altamonte Springs, Florida 1Arlington, Texas 1Austin, Texas 1Baltimore, Maryland 1
Self-screener
Recruiting trials
- Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study
- Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme
- Biomarkers in the Diagnosis and Prognosis of NAFLD
- Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
- Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD
- Evaluation of Non-Invasive Tests for Metabolic Liver Disease
- Fibrosis Lessens After Metabolic Surgery
- Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis
- LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B
- Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft Tissues
- Non-Invasive Model for Fibrosis Regression in HBV Patients
- Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis
- Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients
- Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease
- Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans
Related conditions
Trials recruiting for Liver Fibrosis often also study these conditions. Each links to its own recruiting-trial list.
NASH 218Obesity 1512Type 2 diabetes 891Non-alcoholic Fatty Liver Disease (NAFLD) 10Liver Fat 5Hepatitis B 147Metabolic Dysfunction-Associated Steatotic Liver Disease 13Metabolic Dysfunction Associated Steatohepatitis (MASH) 3Obesity Type 2 Diabetes Mellitus 7Nonalcoholic Steatohepatitis 6
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Liver Fibrosis trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.